Sat. Feb 24th, 2024

The Regenokine program is a non-surgical treatment for osteoarthritis. It was developed by a molecular cell orthopedic specialist from Germany named Peter Wehling.

The treatment, also known as Orthokine or autologous conditioned serum (ACS), uses your own blood to treat your joints. It has been successful in treating a variety of injuries and postponing the need for surgery.

Regenokine is a treatment for pain and inflammation that uses your own blood to concentrate beneficial proteins and then injects them into the affected joint. It is similar to platelet-rich plasma (PRP) therapy, but is more powerful and works for a longer period of time. It has been shown to prevent the need for surgery or reduce the amount of surgery required for those with mild knee osteoarthritis and other musculoskeletal conditions.

During the procedure, your healthcare professional will draw 2 ounces of blood from your arm. It is then processed with zinc etched glass beads to produce IRAP, which contains many anti-inflammatory proteins. It is also believed to contain a protein called Interleukin 1 Receptor Antagonist, which blocks inflammation and helps relieve pain.

Peter Wehling developed the treatment after using it to treat Arabian horses with joint injuries. His treatment was approved for human use in Germany in 2003 and is now used off-label at three sites in the United States licensed by Wehling.

Regenokine, also known as autologous conditioned serum (ACS), concentrates proteins that fight inflammation and promote regeneration. It is injected into the joints to reduce pain and improve function.

The blood is drawn from the patient, heated slightly to separate out the healing components and concentrated, then injected into the injured site. The injection contains a protein that blocks interleukin 1, which is responsible for creating inflammation and pain.

The treatment is popular with professional athletes, who have reported significant pain relief and improved performance. But it has not yet been FDA approved in the US because the body tissues must be minimally manipulated or it would be considered a drug, which requires more rigorous approval. Regenokine can be used in the knees, hips, shoulders, elbows, wrists, temporomandibular joints and lumbar, cervical and thoracic spines. But the most exciting use may be in cartilage regeneration. Wehling’s lab has seen significant improvements in joint cartilage regeneration in mice and in human trials.

Regenokine is a rebranding of an old technology called Orthokine or Autologous Conditioned Serum (ACS). It uses your own blood to create IRAP which targets interleukin-1, a protein that causes inflammation and pain. It is different from PRP in that it cannot repair an injury like stem cells can but does treat inflammation and accelerate healing and tissue regeneration.

It can be used to treat essentially all joints, spinal elements, ligaments and muscles. It works to reduce joint inflammation and decrease the harmful effects of osteoarthritis like pain, mobility issues and impaired function.

It is the treatment of choice for professional athletes like Kobe Bryant, Alex Rodriguez and Fred Couples. It is also the treatment of choice for many patients in New York and Miami who suffer from pain due to chronic back, neck or shoulder injuries. It is the ONLY treatment that has been FDA approved to heal tendons, ligaments and muscle tissue. Beware of NON-DOCTORS offering this therapy in your area that have no medical training.

The Regenokine Program, also known as Orthokine in Europe, is a non-surgical treatment for osteoarthritis and joint pain. Developed by world-renowned molecular cell orthopedic specialist Peter Wehling, this therapy uses your own blood to increase anti-inflammatory proteins and growth factors in the joints to improve mobility, restore function and decrease inflammation.

Unlike PRP injections, which are only designed to alleviate pain, Regenokine can actually slow down the progression of osteoarthritis. It can also prevent the need for surgical replacement of the affected joint.

Wehling and naturopathic physician Chris Renna, who offers Regenokine at his Lifespan Medicine clinic in Dallas and Santa Monica, have found that the results of this innovative procedure are greatly influenced by a patient’s lifestyle. Inflammation-lowering strategies like diet, exercise, sleep and stress management can help maximize the effectiveness of this game-changing treatment. The result is less pain, better movement and a renewed outlook on life. Even high-profile athletes like Kobe Bryant, Lindsey Berg and Alex Rodriguez have found significant improvement in their aches and pains with the Regenokine treatment series.

We invite you to take the first step by booking a consultation with the skilled medical professionals at Los Angeles Pain Relief Clinic, the best Regenokine Program Provider inLos Angeles if you are curious about the Regenokine® Program and how it can fit into your pain management strategy.

By admin

Leave a Reply

Your email address will not be published. Required fields are marked *